IGI+Butyrate
Natural health product licensed in Canada
- Licence holder
- Les Emballages Façoteck
- NPN or DIN-HM
- 80129292
- Status
- Active licence
- Licence date
- 31 January 2024
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Générale (non traditionelle)
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lactiplantibacillus plantarum Source : Lactiplantibacillus Plantarum - Cellule entière | 1 Milliards d'UFC | Not calculated |
| Lactiplantibacillus plantarum Source : KABP-023 | 1 Milliards d'UFC | Not calculated |
Non-medicinal ingredients
Gomme arabique (acacia), Stéarate de magnésium, Trehalose, Dioxyde de silicium, Hypromellose, Dextrose, Ascorbate de sodium, D-Mannitol, Citrate de sodium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 1 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Could promote a favorable gut flora. Helps support intestinal/gastrointestinal health. Source of Probiotics. Helps to improve gut-related stress/discomfort from IBS in 6 weeks. Help improves quality of life in patients with diarrhea-predominant irritable bowel syndrome. Helps improve quality of life by relieving IBS symptoms. Helps reduce symptoms of lactose intolerance such as abdominal pain and flatulence. Helps relief symptoms of irritable bowel syndrome (IBS). Helps improve IBS-related quality of life in patients with IBS and diarrhea. Helps relieve the symptoms of irritable bowel syndrome (IBS) (abdominal pain, bloating, distension). Helps to manage patients' IBS symptoms that impacts their quality of life. Helps improve quality of life in IBS patients by supporting gut health and improving gut comfort. A source of butyric acid, a short chain saturated fatty acids which provides energy.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80129292
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.